-
1
-
-
79955666020
-
Introduction to current and future protein therapeutics: A protein engineering perspective
-
Carter PJ. 2011. Introduction to current and future protein therapeutics: A protein engineering perspective. Exp Cell Res 317:1261-1269.
-
(2011)
Exp Cell Res
, vol.317
, pp. 1261-1269
-
-
Carter, P.J.1
-
2
-
-
77950666079
-
Fresh from the biologic pipeline-2009
-
Sheridan C. 2010. Fresh from the biologic pipeline-2009. Nat Biotechnol 28:307-310.
-
(2010)
Nat Biotechnol
, vol.28
, pp. 307-310
-
-
Sheridan, C.1
-
3
-
-
2642550862
-
Challenges in the development of high protein concentration formulations
-
Shire SJ, Shahrokh Z, Liu J. 2004. Challenges in the development of high protein concentration formulations. J Pharm Sci 93:1390-1402.
-
(2004)
J Pharm Sci
, vol.93
, pp. 1390-1402
-
-
Shire, S.J.1
Shahrokh, Z.2
Liu, J.3
-
4
-
-
79956103081
-
Aggregates in monoclonal antibody manufacturing processes
-
Vázquez-Rey M, Lang DA. 2011. Aggregates in monoclonal antibody manufacturing processes. Biotechnol Bioeng 108:1494-1508.
-
(2011)
Biotechnol Bioeng
, vol.108
, pp. 1494-1508
-
-
Vázquez-Rey, M.1
Lang, D.A.2
-
5
-
-
79851475357
-
Immunogenicity of protein therapeutics: The key causes, consequences and challenges
-
Baker MP, Reynolds HM, Lumicisi B, Bryson CJ. 2010. Immunogenicity of protein therapeutics: The key causes, consequences and challenges. Self Nonself 1:314-322.
-
(2010)
Self Nonself
, vol.1
, pp. 314-322
-
-
Baker, M.P.1
Reynolds, H.M.2
Lumicisi, B.3
Bryson, C.J.4
-
6
-
-
59349083966
-
Protein aggregation kinetics, mechanism, and curve- fitting: A review of the literature
-
Morris AM, Watzky MA, Finke RG. 2009. Protein aggregation kinetics, mechanism, and curve- fitting: A review of the literature. Biochim Biophys Acta 1794:375-397.
-
(2009)
Biochim Biophys Acta
, vol.1794
, pp. 375-397
-
-
Morris, A.M.1
Watzky, M.A.2
Finke, R.G.3
-
7
-
-
79960128166
-
Classification and characterization of therapeutic antibody aggregates
-
Joubert MK, Luo Q, Nashed-Samuel Y, Wypych J, Narhi LO. 2011. Classification and characterization of therapeutic antibody aggregates. J Biol Chem 286:25118-25133.
-
(2011)
J Biol Chem
, vol.286
, pp. 25118-25133
-
-
Joubert, M.K.1
Luo, Q.2
Nashed-Samuel, Y.3
Wypych, J.4
Narhi, L.O.5
-
8
-
-
67449132077
-
Principles, approaches, and challenges for predicting protein aggregation rates and shelf life
-
Weiss WF, Young TM, Roberts CJ. 2009. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci 98:1246-1277.
-
(2009)
J Pharm Sci
, vol.98
, pp. 1246-1277
-
-
Weiss, W.F.1
Young, T.M.2
Roberts, C.J.3
-
9
-
-
36749040335
-
Non-native protein aggregation kinetics
-
Roberts CJ. 2007. Non-native protein aggregation kinetics. Biotechnol Bioeng 98:927-938.
-
(2007)
Biotechnol Bioeng
, vol.98
, pp. 927-938
-
-
Roberts, C.J.1
-
10
-
-
68749118103
-
Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress
-
Hawe A, Kasper JC, Friess W, Jiskoot W. 2009. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. Eur J Pharm Sci 38:79-87.
-
(2009)
Eur J Pharm Sci
, vol.38
, pp. 79-87
-
-
Hawe, A.1
Kasper, J.C.2
Friess, W.3
Jiskoot, W.4
-
11
-
-
68949085124
-
Protein aggregation: Pathways, induction factors and analysis
-
Mahler HC, Friess W, Grauschopf U, Kiese S. 2009. Protein aggregation: Pathways, induction factors and analysis. J Pharm Sci 98:2909-2934.
-
(2009)
J Pharm Sci
, vol.98
, pp. 2909-2934
-
-
Mahler, H.C.1
Friess, W.2
Grauschopf, U.3
Kiese, S.4
-
13
-
-
11844291300
-
Protein aggregation and its inhibition in biopharmaceutics
-
Wang, W. 2005. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289:1-30.
-
(2005)
Int J Pharm
, vol.289
, pp. 1-30
-
-
Wang, W.1
-
14
-
-
77955100181
-
An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics
-
Singh SK, Afonina N, Awwad M, Bechtold-Peters K, Blue JT, Chou D, Cromwell M, Krause HJ, Mahler HC, Meyer BK, Narhi L, Nesta DP, Spitznagel T. 2010. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. J Pharm Sci 99:3302-3321.
-
(2010)
J Pharm Sci
, vol.99
, pp. 3302-3321
-
-
Singh, S.K.1
Afonina, N.2
Awwad, M.3
Bechtold-Peters, K.4
Blue, J.T.5
Chou, D.6
Cromwell, M.7
Krause, H.J.8
Mahler, H.C.9
Meyer, B.K.10
Narhi, L.11
Nesta, D.P.12
Spitznagel, T.13
-
15
-
-
80054717076
-
Protein-excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development
-
Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. 2011. Protein-excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev 63:1118-1159.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, pp. 1118-1159
-
-
Kamerzell, T.J.1
Esfandiary, R.2
Joshi, S.B.3
Middaugh, C.R.4
Volkin, D.B.5
-
16
-
-
84855894631
-
Particles in therapeutic protein formulations, Part 1: Overview of analytical methods
-
Zölls S, Tantipolphan R, Wiggenhorn M, Winter G, Jiskoot W, Friess W, Hawe A. 2012. Particles in therapeutic protein formulations, Part 1: Overview of analytical methods. J Pharm Sci 101:914-935.
-
(2012)
J Pharm Sci
, vol.101
, pp. 914-935
-
-
Zölls, S.1
Tantipolphan, R.2
Wiggenhorn, M.3
Winter, G.4
Jiskoot, W.5
Friess, W.6
Hawe, A.7
-
17
-
-
84855864033
-
Forced degradation of therapeutic proteins
-
Hawe A, Wiggenhorn M, van de Weert M, Garbe JH, Mahler HC, Jiskoot W. 2012. Forced degradation of therapeutic proteins. J Pharm Sci 101:895-913.
-
(2012)
J Pharm Sci
, vol.101
, pp. 895-913
-
-
Hawe, A.1
Wiggenhorn, M.2
van de, W.M.3
Garbe, J.H.4
Mahler, H.C.5
Jiskoot, W.6
-
18
-
-
84855575327
-
A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding
-
Kayser V, Chennamsetty N, Voynov V, Helk B, Forrer K, Trout BL. 2012. A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding. Biotechnol J. 7:127-132.
-
(2012)
Biotechnol J.
, vol.7
, pp. 127-132
-
-
Kayser, V.1
Chennamsetty, N.2
Voynov, V.3
Helk, B.4
Forrer, K.5
Trout, B.L.6
-
19
-
-
77949789023
-
High throughput thermostability screening of monoclonal antibody formulations
-
He F, Hogan S, Latypov RF, Narhi LO, Razinkov VI. 2010. High throughput thermostability screening of monoclonal antibody formulations. J Pharm Sci 99:1707-1720.
-
(2010)
J Pharm Sci
, vol.99
, pp. 1707-1720
-
-
He, F.1
Hogan, S.2
Latypov, R.F.3
Narhi, L.O.4
Razinkov, V.I.5
-
20
-
-
33748525884
-
Computational models for the prediction of polypeptide aggregation propensity
-
Caflisch A. 2006. Computational models for the prediction of polypeptide aggregation propensity. Curr Opin Chem Biol 10:437-444.
-
(2006)
Curr Opin Chem Biol
, vol.10
, pp. 437-444
-
-
Caflisch, A.1
-
21
-
-
5044235541
-
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
-
Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. 2004. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22:1302-1306.
-
(2004)
Nat Biotechnol
, vol.22
, pp. 1302-1306
-
-
Fernandez-Escamilla, A.M.1
Rousseau, F.2
Schymkowitz, J.3
Serrano, L.4
-
23
-
-
0000116343
-
Studies in the physical chemistry of the proteins. VIII. The solubility of hemoglobin in concentrated salt solutions. A study of the salting-out of proteins
-
Green AA. 1931. Studies in the physical chemistry of the proteins. VIII. The solubility of hemoglobin in concentrated salt solutions. A study of the salting-out of proteins. J Biol Chem 93:495-516.
-
(1931)
J Biol Chem
, vol.93
, pp. 495-516
-
-
Green, A.A.1
-
24
-
-
0029792830
-
How Hofmeister ion interactions affect protein stability
-
Baldwin RL. 1996. How Hofmeister ion interactions affect protein stability. Biophys J 71:2056-2063.
-
(1996)
Biophys J
, vol.71
, pp. 2056-2063
-
-
Baldwin, R.L.1
-
25
-
-
0028332007
-
A role for surface hydrophobicity in protein-protein recognition
-
Young L, Jernigan RL, Covell DG. 1994. A role for surface hydrophobicity in protein-protein recognition. Protein Sci 3:717-729.
-
(1994)
Protein Sci
, vol.3
, pp. 717-729
-
-
Young, L.1
Jernigan, R.L.2
Covell, D.G.3
-
26
-
-
44349092523
-
Hydrophobic clusters in protein structures
-
Arunachalam J, Gautham N. 2008. Hydrophobic clusters in protein structures. Proteins 71:2012-2025.
-
(2008)
Proteins
, vol.71
, pp. 2012-2025
-
-
Arunachalam, J.1
Gautham, N.2
-
27
-
-
0031932169
-
Protein aggregation: Folding aggregates, inclusion bodies and amyloid
-
Fink, AL. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 3:R9-R23.
-
(1998)
Fold Des
, vol.3
-
-
Fink, A.L.1
-
28
-
-
55749096388
-
Measuring and increasing protein solubility
-
Trevino SR, Scholtz JM, Pace CN. 2008. Measuring and increasing protein solubility. J Pharm Sci 97:4155-4166.
-
(2008)
J Pharm Sci
, vol.97
, pp. 4155-4166
-
-
Trevino, S.R.1
Scholtz, J.M.2
Pace, C.N.3
-
29
-
-
33846374339
-
Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa
-
Trevino SR, Scholtz JM, Pace CN. 2007. Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa. J Mol Biol 366:449-460.
-
(2007)
J Mol Biol
, vol.366
, pp. 449-460
-
-
Trevino, S.R.1
Scholtz, J.M.2
Pace, C.N.3
-
31
-
-
78651399650
-
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
-
Emanuel SL, Engle LJ, Chao G, Zhu RR, Cao C, Lin Z, Yamniuk AP, Hosbach J, Brown J, Fitzpatrick E, Gokemeijer J, Morin P, Morse BA, Carvajal IM, Fabrizio D, Wright MC, Das Gupta R, Gosselin M, Cataldo D, Ryseck RP, Doyle ML, Wong TW, Camphausen RT, Cload ST, Marsh HN, Gottardis MM, Furfine ES. 2011. A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor. MAbs 3:38-48.
-
(2011)
MAbs
, vol.3
, pp. 38-48
-
-
Emanuel, S.L.1
Engle, L.J.2
Chao, G.3
Zhu, R.R.4
Cao, C.5
Lin, Z.6
Yamniuk, A.P.7
Hosbach, J.8
Brown, J.9
Fitzpatrick, E.10
Gokemeijer, J.11
Morin, P.12
Morse, B.A.13
Carvajal, I.M.14
Fabrizio, D.15
Wright, M.C.16
Das, G.R.17
Gosselin, M.18
Cataldo, D.19
Ryseck, R.P.20
Doyle, M.L.21
Wong, T.W.22
Camphausen, R.T.23
Cload, S.T.24
Marsh, H.N.25
Gottardis, M.M.26
Furfine, E.S.27
more..
-
32
-
-
27144432842
-
Engineered antibody fragments and the rise of single domains
-
Holliger P, Hudson PJ. 2005. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126-1136.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1126-1136
-
-
Holliger, P.1
Hudson, P.J.2
-
33
-
-
84856764818
-
Structures of adnectin/protein complexes reveal an expanded binding footprint
-
Ramamurthy V, Krystek SR Jr, Bush A, Wei A, Emanuel SL, Das Gupta R, Janjua A, Cheng L, Murdock M, Abramczyk B, Cohen D, Lin Z, Morin P, Davis JH, Dabritz M, McLaughlin DC, Russo KA, Chao G, Wright MC, Jenny VA, Engle LJ, Furfine E, Sheriff S. 2012. Structures of adnectin/protein complexes reveal an expanded binding footprint. Structure 20:259-269.
-
(2012)
Structure
, vol.20
, pp. 259-269
-
-
Ramamurthy, V.1
Krystek, S.J.2
Bush, A.3
Wei, A.4
Emanuel, S.L.5
Das, G.R.6
Janjua, A.7
Cheng, L.8
Murdock, M.9
Abramczyk, B.10
Cohen, D.11
Lin, Z.12
Morin, P.13
Davis, J.H.14
Dabritz, M.15
McLaughlin, D.C.16
Russo, K.A.17
Chao, G.18
Wright, M.C.19
Jenny, V.A.20
Engle, L.J.21
Furfine, E.22
Sheriff, S.23
more..
-
34
-
-
11944271430
-
Solubility as a function of protein structure and solvent components
-
Schein CH. 1990. Solubility as a function of protein structure and solvent components. Biotechnology 8:308-317.
-
(1990)
Biotechnology
, vol.8
, pp. 308-317
-
-
Schein, C.H.1
-
35
-
-
84859910800
-
Toward a molecular understanding of protein solubility: Increased negative surface charge correlates with increased solubility
-
Kramer RM, Shende VR, Motl N, Pace CN, Scholtz JM. 2012. Toward a molecular understanding of protein solubility: Increased negative surface charge correlates with increased solubility. Biophys J 102:1907-1915.
-
(2012)
Biophys J
, vol.102
, pp. 1907-1915
-
-
Kramer, R.M.1
Shende, V.R.2
Motl, N.3
Pace, C.N.4
Scholtz, J.M.5
-
36
-
-
79251581274
-
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies
-
Gibson TJ, Mccarty K, Mcfadyen IJ, Cash E, Dalmonte P, Hinds KD, Dinerman AA, Alvarez JC, Volkin DB. 2011. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies. J Pharm Sci 100:1009-1021.
-
(2011)
J Pharm Sci
, vol.100
, pp. 1009-1021
-
-
Gibson, T.J.1
Mccarty, K.2
Mcfadyen, I.J.3
Cash, E.4
Dalmonte, P.5
Hinds, K.D.6
Dinerman, A.A.7
Alvarez, J.C.8
Volkin, D.B.9
-
37
-
-
0029584509
-
Estimation of recombinant bovine somatotropin solubility by excluded-volume interaction with polyethylene glycols
-
Stevenson CL, Hageman MJ. 1995. Estimation of recombinant bovine somatotropin solubility by excluded-volume interaction with polyethylene glycols. Pharm Res. 12:1671-1676.
-
(1995)
Pharm Res.
, vol.12
, pp. 1671-1676
-
-
Stevenson, C.L.1
Hageman, M.J.2
-
38
-
-
84867065769
-
Fc-fusion proteins: New developments and future perspectives
-
Czajkowsky DM, Hu J, Shao Z, Pleass RJ. 2012. Fc-fusion proteins: New developments and future perspectives. EMBO Mol Med 4:1015-1028.
-
(2012)
EMBO Mol Med
, vol.4
, pp. 1015-1028
-
-
Czajkowsky, D.M.1
Hu, J.2
Shao, Z.3
Pleass, R.J.4
-
39
-
-
77952467953
-
Prediction of aggregation prone regions of therapeutic proteins
-
Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Prediction of aggregation prone regions of therapeutic proteins. J Phys Chem B 114:6614-6624.
-
J Phys Chem B
, vol.114
, pp. 6614-6624
-
-
Chennamsetty, N.1
Voynov, V.2
Kayser, V.3
Helk, B.4
Trout, B.L.5
-
40
-
-
67749111952
-
Design of therapeutic proteins with enhanced stability
-
Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. 2009. Design of therapeutic proteins with enhanced stability. Proc Natl Acad Sci USA 106:11937-11942.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 11937-11942
-
-
Chennamsetty, N.1
Voynov, V.2
Kayser, V.3
Helk, B.4
Trout, B.L.5
-
41
-
-
0022147096
-
The Hofmeister effect and the behaviour of water at interfaces
-
Collins KD, Washabaugh MW. 1985. The Hofmeister effect and the behaviour of water at interfaces. Q Rev Biophys 18:323-422.
-
(1985)
Q Rev Biophys
, vol.18
, pp. 323-422
-
-
Collins, K.D.1
Washabaugh, M.W.2
-
42
-
-
84862876623
-
Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies
-
Banks DD, Latypov RF, Ketchem RR, Woodard J, Scavezze JL, Siska CC, Razinkov VI. 2012. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies. J Pharm Sci 101:2720-2732.
-
(2012)
J Pharm Sci
, vol.101
, pp. 2720-2732
-
-
Banks, D.D.1
Latypov, R.F.2
Ketchem, R.R.3
Woodard, J.4
Scavezze, J.L.5
Siska, C.C.6
Razinkov, V.I.7
-
43
-
-
18544397601
-
Directed evolution of high-affinity antibody mimics using mRNA display
-
Xu L, Aha P, Gu K, Kuimelis RG, Kurz M, Lam T, Lim AC, Liu H, Lohse PA, Sun L, Weng S, Wagner RW, Lipovsek D. 2002. Directed evolution of high-affinity antibody mimics using mRNA display. Chem Biol 9:933-942.
-
(2002)
Chem Biol
, vol.9
, pp. 933-942
-
-
Xu, L.1
Aha, P.2
Gu, K.3
Kuimelis, R.G.4
Kurz, M.5
Lam, T.6
Lim, A.C.7
Liu, H.8
Lohse, P.A.9
Sun, L.10
Weng, S.11
Wagner, R.W.12
Lipovsek, D.13
|